TherapeuticsMD
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of TherapeuticsMD generated cash of -$48,141,000, which is less than the previous year. Cash used in financing activities reached the amount of $3,151,000 last year. Net change in cash is therefore -$44,990,000.
Cash Flow
| 2014 | -45.52M | -606.75K | 43.29M |
|---|---|---|---|
| 2015 | -79.04M | -584.36K | 92.97M |
| 2016 | -69.14M | -1.25M | 137.22M |
| 2017 | -76.15M | -827.10K | 72.58M |
| 2018 | -106.81M | -21.49M | 162.78M |
| 2019 | -165.69M | -23.91M | 188.82M |
| 2020 | -159.47M | -1.59M | 80.72M |
| 2021 | -142.69M | -2.22M | 129.55M |
| 2022 | -4.07M | 223.47M | -235.20M |
| 2023 | -48.14M | 0 | 3.15M |
TXMD Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 49.31M | 65.12M | 80.48M | 160.82M | 161.61M | 127.13M | 131.53M | 64.70M | 51.36M | 54.19M |
Operating activities | ||||||||||
Net income | -10.27M | 1.07M | -172.41M | -183.52M | -176.14M | -132.61M | -76.92M | -89.87M | -85.07M | -54.21M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 122K | 1.19M | 4.09M | 4.06M | 1.39M | 293.88K | 213.11K | 132.45K | 62.4K | 52.46K |
Stock-based compensation expense | 1.27M | 11.57M | 18.12M | 10.67M | 10.68M | 0 | 6.88M | 17.41M | 7.18M | 4.23M |
| Deferred income tax benefit | 1.27M | 11.57M | 18.12M | 10.67M | 10.68M | 0 | 6.88M | 17.41M | 7.18M | 4.23M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | -4.32M | -8.19M | -13.63M | -6.95M | 167.69K | -3.97M | -917.65K | -458.02K |
Inventories | 0 | 0 | -711K | -3.33M | -8.59M | -1.78M | -409.03K | -386.16K | 491.96K | -138.49K |
Accounts payable | -2.13M | -1.21M | -750K | 1.88M | -3.56M | 18.64M | -3.26M | 4.23M | -3.20M | 4.21M |
Cash generated by operating activities | -48.14M | -4.07M | -142.69M | -159.47M | -165.69M | -106.81M | -76.15M | -69.14M | -79.04M | -45.52M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -355K | -2.22M | -1.59M | -23.89M | -21.32M | -827.10K | -1.24M | -584.36K | -617.44K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 223.47M | -2.22M | -1.59M | -23.91M | -21.49M | -827.10K | -1.25M | -584.36K | -606.75K |
Financing activities | ||||||||||
Common Stock Issued | 3.15M | 24.15M | 184.11M | 31.70M | 77.03M | 89.90M | 68.57M | 134.86M | 91.37M | 42.77M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -38.65M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -219.43M | -50M | -48.75M | 118.33M | -71.21M | 0 | 0 | 0 | 0 |
Cash used in financing activities | 3.15M | -235.20M | 129.55M | 80.72M | 188.82M | 162.78M | 72.58M | 137.22M | 92.97M | 43.29M |
Net Change In Cash | -44.99M | -15.80M | -15.36M | -80.34M | -783.36K | 34.47M | -4.39M | 66.82M | 13.34M | -2.82M |
Cash at end of period | 4.32M | 49.31M | 65.12M | 80.48M | 160.82M | 161.61M | 127.13M | 131.53M | 64.70M | 51.36M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |